GLP-3-R
Tri-receptor incretin research analog
How researchers describe GLP-3-R
Multi-receptor incretin analog reported in published preclinical work to engage GLP-1R, GIP-R, and glucagon receptor pathways in cultured cells and rodent models. Investigators studying this compound focus on cAMP/PKA-mediated signaling cascades downstream of these class-B GPCRs and their effects on insulin and glucose-handling endpoints in vitro.
- GLP-1R / GIP-R / GCGR (class-B GPCRs)
- cAMP → PKA → CREB
- PI3K / Akt insulin sensitivity arm
Lyophilized at −20°C. Reconstitution and stability are set by the end researcher; no use-window or dosing guidance is provided.
Per-lot supplier COA (HPLC + LC-MS)
- HPLC + LC-MS laboratory analysis on every lot
- Reported purity ≥99.1%
- Sealed glass vial, butyl stopper, crimp cap
- Frias et al., 2018 — GIP/GLP-1 dual receptor agonism, NEJM
- Coskun et al., 2018 — LY3298176 dual GIP/GLP-1, Mol Metab
Common researcher questions
Is this for human use?+
No. All X Factor research peptides are RUO — sold solely for in-vitro and non-clinical preclinical research. Not for human or veterinary use, food, supplement, cosmetic, or therapeutic application.
How is purity verified?+
Every lot ships with the supplier’s per-lot COA (HPLC purity, plus LC-MS identity where applicable). COA available per lot — request via contact form.
How is it shipped?+
Lyophilized peptide in a sealed glass vial, packed in discreet outer packaging, shipped from our US fulfillment partner. Blends ship with cold-pack on request.
Can I get a COA before ordering?+
Yes — contact us with the SKU and we will email the most recent lot COA. We also publish the COA vault to verified researchers post-purchase.
Restock for OOS items?+
Use the Notify-Me form on the catalog page. We email when the lot is QC-passed and live. No spam, single-use.